SCHEMBL2107756

SCHEMBL2107756

NC(=O)CC(N)=O.c1ncc2sccc2n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
NTRK1 P04629 1/20 0.33
P2RX7 Q99572 1/20 0.33
BAZ1A Q9NRL2 1/20 0.32
ADORA2B P29275 2/20 0.32
MAPK8 P45983 2/20 0.32
IRAK4 Q9NWZ3 3/20 0.31
AXL P30530 1/20 0.31
MKNK1 Q9BUB5 1/20 0.31
MKNK2 Q9HBH9 1/20 0.31
RPS6KB1 P23443 1/20 0.31
AKT1 P31749 1/20 0.31
ADORA2A P29274 1/20 0.31
SYK P43405 1/20 0.30
IRAK1 P51617 1/20 0.30
AR P10275 1/20 0.30
EGFR P00533 3/20 0.30
PRMT3 O60678 1/20 0.30
PDE4A P27815 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL28122176 0.90 AXL (0.34) ALDH1A1GAANTRK1BAZ1AADORA2B
Hydrazine SCHEMBL5897595 0.83 AXL (0.38) ALDH1A1NTRK1MAPK8AXLMKNK1
SCHEMBL32388 0.83
SCHEMBL27747567 0.83 AXL (0.41) ALDH1A1IRAK4AXLMKNK1MKNK2
Acetic Acid SCHEMBL474261 0.82 ADORA2A (0.35) ALDH1A1NTRK1BAZ1AADORA2BIRAK4
Acetic Acid SCHEMBL28002200 0.82 ADORA2A (0.35) ALDH1A1NTRK1ADORA2BIRAK4ADORA2A
Formaldehyde SCHEMBL28037402 0.81 AXL (0.37) ALDH1A1NTRK1AXLMKNK1MKNK2
Hydrochloric Acid SCHEMBL21803551 0.81 AXL (0.39) ALDH1A1IRAK4AXLMKNK1MKNK2
SCHEMBL30711136 0.81 AXL (0.39) ALDH1A1IRAK4AXLMKNK1MKNK2
SCHEMBL29588937 0.81 PIP4K2C (0.40) ALDH1A1NTRK1BAZ1AADORA2BIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896395-B1 MODIFIED MALONATE DERIVATIVES MERCK SHARP & DOHME (US) 2015-07-15 EP disclosed
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed
EP-1896395-A2 MODIFIED MALONATE DERIVATIVES Merck & Co., Inc. (US) 2008-03-12 EP disclosed
WO-2007002248-A2 MODIFIED MALONATE DERIVATIVES MERCK & CO., INC. (US) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 ALDH1A1 784/4885GAA 713/4885NTRK1 1229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.